Lisdexamfetamine dimesylate had no apparent effects on embryo-fetal morphological development or survival when administered orally to pregnant rats and rabbits throughout the period of organogenesis at doses of up to 40 and 120 mg/kg/day, respectively. Your healthcare provider should check you or your child’s risk for abuse, misuse, and addiction https://juliani566uxx8.wikicorrespondence.com/user